Covaxin Gets Approval For Emergency Use In Nepal


The Rising Nepal

By Saroj Dhungel, Kathmandu, Mar. 19: The Department of Drug Administration (DDA) has given approval to ‘Covaxin’, a vaccine against novel coronavirus, for emergency use in Nepal.

Covaxin is being produced by an Indian company called Bharat Biotech International Limited.

Bharat Bhattarai, Director General at the DDA informed The Rising Nepal that approval had been given to use Covaxin in emergencies.

With this, the number of companies receiving Nepal’s approval for use has reached three. Prior to this, Covishield and Sinopharm had received the government’s nod for emergency use.

Similarly, Bhattarai said that two more companies producing COVID-19 vaccines had filed applications at the department for approval. “Russia’s Sputnik V and China’s Sinovac have applied to receive approval for use,” he said.

Director-General Bhattarai added that the technical team of the department was investigating the vaccines.

The DDA gave approval to Covaxin on Friday on the recommendation of the Drug Advisory Committee.